ConductScience.org, home
SLC29A1: solute carrier family 29 member 1 (Augustine blood group)
API referenceFor AI assistants

Gene · 2030

Papers2,306

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 2,306

Download this page as JSON
TitleJournalYearPMIDFound bySource
Tissue compartment limits the apparent late-stage decline in hepatic ENT1.Metabolism202642790774PubTator, text miningPubMed
Nucleolin shields PTBP1 from autophagic degradation to sustain gemcitabine resistance in bladder cancer.Drug Resist Updat202642790162PubTator, text miningPubMed
Response to "Tissue compartment limits the apparent late-stage decline in hepatic ENT1".Metabolism202642753861PubTator, text miningPubMed
Enhancing gemcitabine uptake by promoting dimerization of ENT1 transporter improves response rates of patients with sarcoma.J Clin Invest202642691249PubTator, text miningPubMed
The Potential of Cannabidiol for the Treatment of Psychosis: Endocannabinoid Regulation of Serotonergic Neurotransmission via Serotonin 5-HT1A/2A Receptors.Neurochem Res202642658346PubTator, text miningPubMed
Anticonvulsant effects, safety, and sex-dependent molecular signatures of cannabidiol treatment in a preclinical model of audiogenic epilepsy.Front Pharmacol202642630256PubTator, text miningPubMed
Construction and validation of a nomogram for the diagnosis of postmenopausal osteoporosis.Mol Med Rep202642596822PubTator, text miningPubMed
ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma.Drug Resist Updat202642585696PubTator, text miningPubMed
Pan-cancer multi-omics analysis of pharmacogenomic alterations.Front Bioinform202642558488PubTator, text miningPubMed
Repurposed cAMP-Modulating Agents Enhance 5-Fluorouracil Response Through Membrane-Dependent Mechanisms.Membranes (Basel)202642506183PubTator, text miningPubMed
Equilibrative nucleoside transporter 1 deficiency protects against diet-induced MASLD and is stage-associated in human liver disease.Metabolism202642480862PubTator, text miningPubMed
Metabolic and Molecular Mechanisms of Gemcitabine Resistance in Urothelial Carcinoma.Cancers (Basel)202642449668PubTator, text miningPubMed
Metabolomic profiling delineates the role of adenosine in oocyte quality and embryonic development.Cell Death Dis202642265076PubTator, text miningPubMed
Computational evaluation of leflunomide and ticagrelor combination targeting the A2A receptor for the management of rheumatoid arthritis.Pak J Pharm Sci202642262197PubTator, text miningPubMed
Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study.Br J Clin Pharmacol202642220058PubTator, text miningPubMed
Genomic Biomarkers for First-Line Treatment Selection in Metastatic Pancreatic Ductal Adenocarcinoma: A Narrative Review.Cancers (Basel)202642193022PubTator, text miningPubMed
Inhibition of purine nucleoside and nucleobase transporters by tyrosine kinase inhibitors.PLoS One202642139231PubTator, text miningPubMed
Targeting purinergic signaling and MTAP-associated metabolism in cancer: A functional immunometabolic convergence framework.Biochem Pharmacol202642082122PubTator, text miningPubMed
Epigenetic Biomarkers for Predicting Nucleoside Analog Drug Response and Resistance in Cancer.Biomolecules202642072708PubTator, text miningPubMed
[Inhibitory effect and mechanism of low-intensity ultrasound combined with 5-fluorouracil on human hepatocellular carcinoma HepG2 cells].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi202642020322PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2030/papers

API referenceFor AI assistants